Salesforce is set to rebound after a recent pullback. How trader Tony Zhang is playing the bounce

Salesforce's Agentforce AI annual recurring revenue exceeded $1.5 billion in Q2, growing more than 240% year over year, while the company raised full-year revenue guidance to $46.1 billion-$46.4 billion. CRM fell to roughly $230 following a Dreamforce-period global outage and renewed AI-disruption concerns, despite analysts including Guggenheim and Stifel maintaining or raising $300 targets and management reaffirming a $63 billion fiscal-2030 revenue goal. The article presents a defined-risk bullish Oct. 2026 $230/$215 put spread for a $5.52 credit, with $552 maximum reward and $948 maximum risk.

Analysis

The investable question is not whether CRM can sell AI, but whether Agentforce is incremental software spend or a migration of existing seat and workflow budgets. If it remains additive, CRM's installed-base distribution and data/workflow ownership should support estimate revisions over the next 1-3 quarters; if customers consolidate AI tooling around hyperscalers or OpenAI-native applications, CRM's apparent valuation discount is deserved. Near-term outage-related churn is likely immaterial unless it reveals recurring reliability issues in regulated verticals, where uptime can affect renewal negotiations and implementation cycles.

The second-order beneficiary of CRM's AI adoption is the enterprise implementation ecosystem—ACN, GLOB and EPAM—if agent deployments require data cleanup, system integration and governance. Conversely, NOW and MSFT are the more relevant competitive hedges than generic software: ServiceNow competes for workflow automation budgets, while Microsoft can bundle copilots into an already-funded productivity stack. The market is likely pricing a binary "AI disrupts SaaS" narrative, but the more plausible 6-18 month outcome is margin pressure on low-switching-cost point solutions while systems of record monetize governance, permissions and proprietary customer data.

The proposed short put spread has poor institutional asymmetry if the quoted credit is reliable: risking $9.48 to make $5.52 is only 0.58x reward/risk and leaves substantial downside exposure through an earnings or AI-demand reset. A better expression is outright equity or a call spread after confirming that AI ARR converts into net-new subscription revenue, remaining-performance-obligation growth, and stable gross retention. Thesis falsifiers are a material cut to forward subscription/revenue guidance, deceleration in AI bookings for two consecutive quarters, deterioration in large-deal sales cycles, or a renewed outage that drives public enterprise customer escalation.

Key Decisions for Investors

• Initiate a 1-3 month long CRM / short NOW pair, sized beta-neutral, only if CRM holds above the post-event low and software breadth remains constructive. The trade isolates CRM's installed-base AI monetization versus NOW's richer workflow-AI expectations; exit on CRM guidance reduction or relative underperformance of 10% from entry.
• For directional exposure, buy CRM shares in tranches rather than sell the advertised 230/215 put spread. Start with one-third on stabilization, add after the next earnings release only if AI bookings and RPO support upward FY estimates; target a rerating toward peer multiples over 6-12 months, with a stop on a close below the event low.
• Use CRM 6-9 month call spreads, funded only partially with an out-of-the-money put sale if volatility is elevated, rather than a near-the-money naked downside structure. A 250/290 call spread is appropriate only after option-chain pricing confirms at least 2:1 upside-to-premium risk.
• Monitor ACN and GLOB for corroboration: improving bookings/commentary around Salesforce AI implementation would validate that deployments are moving from pilots to production. Lack of services demand despite reported AI ARR would suggest upsell/repackaging rather than durable incremental spend.